Cited 0 times in 
Cited 0 times in 
PS2-1 Trastuzumab deruxtecan vs T-DM1 in HER2+ mBC in Asian subgroup: Results of the randomized phase 3 study DESTINY-Breast03
https://orcid.org/0000-0002-1595-6342Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.